Cargando…
Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase
Pharmacological activation of the E3 ligase Parkin represents a rational therapeutic intervention for the treatment of Parkinson’s disease. Here we identify several compounds that enhance the activity of wildtype Parkin in the presence of phospho-ubiquitin and act as positive allosteric modulators (...
Autores principales: | Shlevkov, Evgeny, Murugan, Paramasivam, Montagna, Dan, Stefan, Eric, Hadzipasic, Adelajda, Harvey, James S., Kumar, P. Rajesh, Entova, Sonya, Bansal, Nupur, Bickford, Shari, Wong, Lai-Yee, Hirst, Warren D., Weihofen, Andreas, Silvian, Laura F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733272/ https://www.ncbi.nlm.nih.gov/pubmed/35024585 http://dx.doi.org/10.1016/j.isci.2021.103650 |
Ejemplares similares
-
Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
por: Bantle, Collin M., et al.
Publicado: (2021) -
Ancient Origins of Allosteric Activation in a Ser/Thr Kinase
por: Hadzipasic, Adelajda, et al.
Publicado: (2020) -
Lysine 27 Ubiquitination of the Mitochondrial Transport Protein Miro Is Dependent on Serine 65 of the Parkin Ubiquitin Ligase
por: Birsa, Nicol, et al.
Publicado: (2014) -
PINK1/Parkin Pathway Activation for Mitochondrial Quality Control – Which Is the Best Molecular Target for Therapy?
por: Silvian, Laura F.
Publicado: (2022) -
Structure of the human Parkin ligase domain in an autoinhibited state
por: Wauer, Tobias, et al.
Publicado: (2013)